EcoDrugPlus

Carbonic Anhydrase Va

Ensembl ID : ENSGACG00000003213
Gene Symbol: CA5A
1 Cross references
231 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSGACG00000011803
Gene Symbol: CA14
1 Cross references
211 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSGACG00000007378
Gene Symbol: CSNK1E
1 Cross references
199 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSGACG00000004568
Gene Symbol: CSNK1E
1 Cross references
205 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSGACG00000005579
Gene Symbol: CASP9
1 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSGACG00000012090
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSGACG00000007985
Gene Symbol: CTSC
1 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSGACG00000013402
Gene Symbol: CTSK
1 Cross references
226 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSGACG00000013470
Gene Symbol: CTSS2.1
1 Cross references
235 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSGACG00000015684
Gene Symbol: CDC7
1 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSGACG00000020635
Gene Symbol: CHEK1
1 Cross references
179 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSGACG00000002449
Gene Symbol: CCR9A
1 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).